Evidence map›Paper›PMID 42164118›Full record

ArticleFrontiers in oncology2026

MRI features of craniopharyngiomas in different age groups and pathological subtypes.

Weijian Wang, Wenjing Li, Xinyu Wang, Yichen Guo, Longyao Ma, Bohui Mei, Mengzhe Zhang, Hongwei Zheng, Kaixin Li, Mengzhu Wang and 2 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Weijian WangDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Wenjing LiDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xinyu WangDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yichen GuoDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Longyao MaDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Bohui MeiDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Mengzhe ZhangDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Hongwei ZhengDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Kaixin LiMR Research Collaboration, Siemens Healthineers Ltd., Beijing, China.
Mengzhu WangMR Research Collaboration, Siemens Healthineers Ltd., Beijing, China.
Ankang GaoDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yong ZhangDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the MRI features of different pathological types in adult and juvenile patients with craniopharyngioma. Materials and methods: The preoperative MRI images of 68 patients with pathologically confirmed craniopharyngioma were retrospectively analyzed. The tumor location, imaging findings and surrounding tissue involvement were determined, and the tumor volume was measured. The differences of these imaging indicators and pathological types between 48 adult and 20 juvenile groups were compared. Results: Grouped by age: The proportions of adamantinomatous craniopharyngioma (ACP) in the juvenile group and adult group were 85.0% and 56.3%, respectively, with a significant difference (P = 0.024). The predilection sites of craniopharyngioma differed between the juvenile and adult groups. Tumors in the juvenile group were most frequently located in the intrasellar or suprasellar region (80%), whereas those in the adult group were predominantly suprasellar (60.4%), with a significant difference (P<0.001). The incidence of tumor calcification was 55.0% in the juvenile group and 29.1% in the adult group, with a significant difference (P = 0.044). Grouped by pathological subtype: The mean ages at onset were 27 years for ACP and 43 years for SPCP, with a significant difference (P<0.001). The incidence of cystic degeneration was 95.5% in ACP and 83.3% in SPCP, with a significant difference (P = 0.037). Fluid-fluid levels or sediment were present in 20.5% of ACP, but absent in all SPCP, with a significant difference (P = 0.022). Patients in the non-third ventricular floor invasion group were younger and had a wider age range than those in the third ventricular floor invasion group(P = 0.025). Conclusion: There is a close correlation between age at onset, pathological subtype, and MRI features of craniopharyngiomas. ACP is more common in juvenile patients, with a higher tendency toward intrasellar/suprasellar location, calcification, and cystic degeneration. In adult patients, lesions are predominantly suprasellar and more frequently accompanied by pituitary involvement. ACP show a higher cystic degeneration rate with characteristic fluid-fluid levels or sediment, which can be used for preoperative pathological differentiation. Meanwhile, invasion of the floor of the third ventricle is more commonly seen in older patients, suggesting that age may assist in evaluating the invasive growth pattern of craniopharyngiomas.

Indexed as

adamantinomatous craniopharyngiomaadultjuvenilemagnetic resonance imagingsquamous papillary craniopharyngioma

Identifiers

PMID42164118
PMCPMC13183521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.